NYLIM
OGN icon

New York Life Investment Management’s Organon & Co OGN Stock Holding History

New York Life Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-68,292
Closed -$1.19M – 1329
2023
Q3 		$1.19M Buy
68,292
+18,590
+37% +$388K 0.01% 596
2023
Q2 		$1.03M Buy
49,702
+12,271
+33% +$267K 0.01% 593
2023
Q1 		$880K Buy
37,431
+227
+0.6% +$6.09K 0.01% 616
2022
Q4 		$1.04M Sell
37,204
-3,173
-8% -$81.1K 0.01% 621
2022
Q3 		$946K Buy
40,377
+261
+0.7% +$7.88K 0.01% 622
2022
Q2 		$1.35M Buy
+40,116
New +$1.41M 0.02% 578

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

New York Life Investment Management's OGN Position: Q4 2023 in Review

New York Life Investment Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 68,292 shares — an estimated $1.19M sold.

New York Life Investment Management first reported a position in OGN in Q2 2022 and held it in 6 quarters. The position peaked at $1.35M in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • New York Life Investment Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • New York Life Investment Management sold 68,292 Organon & Co shares in Q4 2023, an estimated $1.19M.
  • New York Life Investment Management first reported a position in Organon & Co in Q2 2022 and held it in 6 quarters.
  • New York Life Investment Management's Organon & Co position peaked at $1.35M in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on New York Life Investment Management's 13F filing for Q4 2023, filed 6 Feb 2024.